Home > Insider Trading > Elan Plc

Elan Plc (ELN)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
51 - 60

Hedge Funds Aren't Crazy About Elan Corporation, plc (ADR) (NYSE:ELN) Anymore

Elan Corporation, plc (ADR) (NYSE:ELN) was in 22 hedge funds' portfolio at the end of December. ELN shareholders have witnessed a decrease in activity from the world's largest hedge funds lately.

Keep Reading →

March 25th, 2013 - News

Better Biotech Buy: Biogen Idec Inc. (BIIB) vs. Celgene Corporation (CELG)

Buying big pharma stocks isn't the only way you can invest in today's best-selling drugs without taking a gamble on a small, risky biotech.

Keep Reading →

March 18th, 2013 - News

Will Eli Lilly & Co. (LLY) Help You Retire Rich? - GlaxoSmithKline plc (ADR) (GSK), Johnson & Johnson (JNJ)

Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.

Keep Reading →

March 7th, 2013 - News

The Fight Over This Biotech's Cash: Elan Corporation, plc (ADR) (ELN)

Elan Corporation, plc (ADR) (NYSE:ELN) was nice enough to give us a little more detail on what it plans to do with the $3.25 million that the biotech stands to get from Biogen Idec Inc.

Keep Reading →

February 25th, 2013 - News

Elan Corporation, plc (ADR) (ELN) Received Buyout Bid Before Buyback

When Elan Corporation, plc (ADR) (NYSE:ELN) sold its stake in the blockbuster selling multiple sclerosis drug Tysabri to partner Biogen Idec Inc.

Keep Reading →

February 25th, 2013 - News

BioMarin Pharmaceutical Inc. (BMRN) Earnings: An Early Look

Earnings season is now starting to wind down, with most companies already having reported their quarterly results. But there are still some companies left to report, and BioMarin Pharmaceutical Inc.

Keep Reading →

February 19th, 2013 - News

Has Avanir Pharmaceuticals, Inc. (AVNR) Become the Perfect Stock?

One thing's for sure: You'll never discover truly great investments unless you actively look for them.

Keep Reading →

February 18th, 2013 - News

Why Elan Corporation, plc (ELN) Cut Its Ties To Tysabri

Elan Corporation, plc (NYSE:ELN) just announced a restructuring of its Tysabri collaboration with Biogen Idec Inc.

Keep Reading →

February 12th, 2013 - News

Has Elan Corporation, plc (ADR) (ELN) Become the Perfect Stock?

One thing's for sure: You'll never discover truly great investments unless you actively look for them.

Keep Reading →

February 11th, 2013 - News

A Win-Win Multiple Sclerosis Deal? - Biogen Idec Inc. (BIIB), Elan Corporation, plc (ELN)

Biogen Idec Inc. (NASDAQ:BIIB) is buying the full rights to multiple sclerosis drug Tysabri from Elan Corporation, plc (ADR) (NYSE:ELN) for $3.25 billion.

Keep Reading →

February 6th, 2013 - News